Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of a Contraceptive Pathway on Contraception Continuation Rates

NCT03925116 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT03925116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03925116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of a Contraceptive Pathway on Contraception Continuation Rates
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Not applicable
Overall status
Suspended
Start date
January 3, 2023
Completion date
June 30, 2024
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contraceptive usage